Rizonib 250 mg (Crizotinib)
Rizonib (Crizotinib), general Xalkori is a traditional drug used to treat ALK (Anaplastic Carcinoma Kinase) OR ROS1 Advanced Non-Small Cell Lung Cancer (NSCLC) which is extended to another corridor of the body. Rizonib is manufactured by Drug International Pharma Ltd. in Bangladesh.
Have to take orally doubly diurnal with/ without food.
The most common adverse responses (≥ 25) are
Visual disturbance, nausea, diarrhea, puking, edema, constipation, elevated transaminase, fatigue, dropped appetite, upper respiratory tract infection, dizziness, and neuropathy.
The below information comes from the Internet. Please consult with the croaker for medical advice.
* Any advice on the use of the medicine is for reference only. Please consult with the croaker for medical advice. All Names, ensigns, and trademarks are the property of their separate possessors. Watermarks and QR canons are used for identification purposes only.